TY - JOUR
T1 - Systemic inflammatory immune signatures in a patient with CRB1 linked retinal dystrophy
AU - Verhagen, Fleurieke
AU - Kuiper, Jonas
AU - Nierkens, Stefan
AU - Imhof, Saskia M.
AU - Radstake, Timothy
AU - de Boer, Joke
N1 - Publisher Copyright:
© 2016 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2016/12/1
Y1 - 2016/12/1
N2 - Background: In this report we describe, for the first time, the activation of the peripheral immune compartment in a patient with a CRB1 linked retinal degenerative disease, masquerading as intermediate uveitis. Methods: To monitor the immune system during systemic immunosuppressive treatment, given for the initial diagnosis of intermediate uveitis, blood samples were taken before and during therapy, for analysis of peripheral blood mononuclear cell-subsets and circulating immune mediators. Results: The levels of various pro-inflammatory immune mediators (including MIF, TSLP, CCL2/MCP-1, CXCL9, CXCL10, IFN-β, IL-6, IL-17, IL-21, IL-22, and IL-23) were elevated in serum at the first time point, and decreased under immunosuppressive treatment. In parallel, the frequency of activated (CD86+) CD1c+ myeloid dendritic cells in blood was proportional to the central foveal thickness measured by optical coherence tomography. Conclusions: These observations challenge the current view on the distinct pathophysiology of retinal degenerative and retinal inflammatory conditions in this patient.
AB - Background: In this report we describe, for the first time, the activation of the peripheral immune compartment in a patient with a CRB1 linked retinal degenerative disease, masquerading as intermediate uveitis. Methods: To monitor the immune system during systemic immunosuppressive treatment, given for the initial diagnosis of intermediate uveitis, blood samples were taken before and during therapy, for analysis of peripheral blood mononuclear cell-subsets and circulating immune mediators. Results: The levels of various pro-inflammatory immune mediators (including MIF, TSLP, CCL2/MCP-1, CXCL9, CXCL10, IFN-β, IL-6, IL-17, IL-21, IL-22, and IL-23) were elevated in serum at the first time point, and decreased under immunosuppressive treatment. In parallel, the frequency of activated (CD86+) CD1c+ myeloid dendritic cells in blood was proportional to the central foveal thickness measured by optical coherence tomography. Conclusions: These observations challenge the current view on the distinct pathophysiology of retinal degenerative and retinal inflammatory conditions in this patient.
KW - CRB1 mutation
KW - cytokine analysis
KW - flow cytometry
KW - Retinal degenerative disease
KW - uveitis
UR - http://www.scopus.com/inward/record.url?scp=84990227465&partnerID=8YFLogxK
U2 - 10.1080/1744666X.2016.1241709
DO - 10.1080/1744666X.2016.1241709
M3 - Article
C2 - 27690673
AN - SCOPUS:84990227465
SN - 1744-666X
VL - 12
SP - 1359
EP - 1362
JO - Expert Review of Clinical Immunology
JF - Expert Review of Clinical Immunology
IS - 12
ER -